Pfizer Foundation offers $2M in grants to NGOs tackling antimicrobial resistance; Biogen, Invitae join forces to develop faster SMA diagnostic
→ Most of Big Pharma has left the building when it comes to antimicrobial drug development, and small companies with newly approved antibiotics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
